Skip to main content
Children's zyrtec products

ZYRTEC®

Recommend Children’s ZYRTEC® right at the start of symptoms* to provide proven effective allergy relief for kids ages 2+

*ZYRTEC® relieves sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat.

Why Children’s ZYRTEC®?

Children’s ZYRTEC® effectively relieves children’s worst allergy symptoms: sneezing, runny nose, itchy, watery eyes, and itching of the nose or throat. 

Count on Children’s ZYRTEC® to provide 24-hour relief with convenient once-daily dosing. The syrup comes in kid-friendly flavors, grape and bubble gum, both sugar- and dye-free. While the convenient dissolve tabs melt in the mouth—so there's no need for water.

ZYRTEC® is the #1 pediatrician recommended brand for children's allergies.

Among OTC oral antihistamines.

Efficacy/ 2-6

Powerful symptom response¹ in patients ages 2 to 6 years old


 

Zyrtec efficacy

Children’s ZYRTEC® 5 mg provides a significant impact1* on allergies in patients ages 2 to 6 years old with seasonal allergic rhinitis (SAR)

Percentage of children demonstrating ≥50% improvement from baseline SAR symptoms over 2 weeks.

Randomized, placebo-controlled study of children aged 2 to 6 years with SAR during a 2-week period. Primary endpoint was the change in Total Symptom Score Complex from baseline.

*Significant vs placebo.

ZYRTEC® 5 mg vs placebo ratio at ≥50% reduction is 1.84-fold.

Efficacy/ 6-12

Powerful symptom response¹ in patients ages 6 to 12 years old


 

Zyrtec efficacy trials with placebo

Children’s ZYRTEC® 10 mg provides a significant impact*1 on allergies in patients ages 6 to 12 years old with seasonal allergic rhinitis (SAR)

Percentage of children demonstrating ≥50% improvement from baseline SAR symptoms over 2 weeks.

Randomized, placebo-controlled studies of children aged 6 to 12 years with SAR during a 2-week period. Primary endpoint was the change in Total Symptom Score Complex from baseline.

*Significant vs placebo.

ZYRTEC® 10 mg vs placebo ratio at ≥50% reduction is 1.88-fold in Study 1 and 1.42-fold in Study 2.

Consistent relief of seasonal allergic rhinitis symptoms2


zyrtec chart

Reduction from baseline in Total Symptom Severity Complex (TSSC)*

Improvement maintained throughout 2 weeks of regular use

  • Percent reductions from baseline TSSC score were 37% and 40%, respectively, after 2 weeks of treatment in the 10-mg group
  • Percent reductions from baseline TSSC score were 63% and 40%, respectively, after 2 weeks of treatment in the 5-mg group

All studies are multicenter, randomized, placebo-controlled, double-blind; children ages 2 to 11 years with previous diagnosis of SAR, and adequate minimum duration (2 weeks).

*TSSC = Total Symptom Severity Complex.

Adjusted mean change relative to baseline.

Symptom relief that is generally well tolerated1


In clinical trials of children ages 6 to 11 years

4.2% of patients taking ZYRTEC® 10 mg reported somnolence (n=215) vs 1.3% with placebo (n=309)¹

≤1% of ZYRTEC® patients discontinued due to somnolence¹


 

Want to learn more about Children's ZYRTEC®?


Resources for allergy care

Share these resources with caregivers to help manage kids’ allergies.


 

Rhinocort products

Children’s RHINOCORT® Allergy spray: tough on allergies, not on noses

Pediatric BundleBox J&J

Discover samples and resources for your patients